최근 5년간 인천지역 설사환자에서 분리한 Salmonella Enteritidis와 Salmonella Typhimurium의 항생제 내성 양상
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 장재선 | - |
dc.contributor.author | 이제만 | - |
dc.contributor.author | 공용우 | - |
dc.contributor.author | 이미연 | - |
dc.date.available | 2020-02-29T02:45:10Z | - |
dc.date.created | 2020-02-12 | - |
dc.date.issued | 2013 | - |
dc.identifier.issn | 1738-4087 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/gachon/handle/2020.sw.gachon/15421 | - |
dc.description.abstract | Objectives: Antimicrobial resistance and multidrug resistance patterns have been studied with a total of 189samples of Salmonella Enteritidis and Salmonella Typhimurium isolated from diarrhea patients in Incheon from 2008 to 2012. Methods: Antimicrobial resistance tests were determined by Disc Diffusion method. Results: The serological distribution of Salmonella spp. showed 108 strains (30.1%) of S. Enteritidis, 81 strains (22.6%) of S. Typhimirium, eight strains (8.0%) of S. Typhi, 11 strains ( 3.1% ) of S. Paratyphi, and the 151other strains (42.1%). The separation rate of Salmonella spp. by year showed 14.5% (52 strains) in 2008, 13.6%(49 strains) in 2009, 22.8% (82 strains) in 2010, 25.3% (91 strains) in 2011, and 23.7% (85 strains) in 2012. Additionally, the separation rate of S. Enteritidis and S. Typhimirium in 2010 was the highest. The Salmonella spp. isolated from diarrhea patients showed significant differences according to age (p<0.05), gender (p<0.01)and medical institution (p<0.05). The highest resistance was found to the following antimicrobial agents:imipenem 77 strains, ampicillin 47 strains, ciprofloxacin 34 strains, nalidixic acid 29 strains for S. Enteritidis,and ampicillin 45 strains, nalidixic acid 45 strains for S. Typhimurium. Separated S. Enteritidis and S. Typhimurium resistance to the antibiotics by the year showed significant differences (p <0.05). The patterns of multidrug resistance rates were 43.1% (47 strains) for one drug, 8.3% (9 strains) for two drugs, 11.0% (12strains) for three drugs, 15.62% (17 strains) for four drugs, and 13.7% (15 strains) for five or more drugs for S. Enteritidis. For S. Tyhpimurium, the rates were 15.0% (12 strains) for one drug, 10.0% (8 strains) for two drugs, 6.3% (five strains) for three drugs, 18.7% (15 strains) for four drugs, and 23.8% (19 strains) for five or more drugs. Conclusion: The antibiotic resistance issue is directly related to people's lives. Thus, the usage of antibiotics should be reduced in order to manage antibiotic resistance. | - |
dc.language | 한국어 | - |
dc.language.iso | ko | - |
dc.publisher | 한국환경보건학회 | - |
dc.relation.isPartOf | 한국환경보건학회지 | - |
dc.title | 최근 5년간 인천지역 설사환자에서 분리한 Salmonella Enteritidis와 Salmonella Typhimurium의 항생제 내성 양상 | - |
dc.title.alternative | Antimicrobial Resistance Patterns of Salmonella Enteritidis and Salmonella Typhimurium Isolated from Diarrhea Patientsin Incheon between 2008 and 2012 | - |
dc.type | Article | - |
dc.type.rims | ART | - |
dc.description.journalClass | 2 | - |
dc.identifier.doi | 10.5668/JEHS.2013.39.3.239 | - |
dc.identifier.bibliographicCitation | 한국환경보건학회지, v.39, no.3, pp.239 - 246 | - |
dc.identifier.kciid | ART001779331 | - |
dc.citation.endPage | 246 | - |
dc.citation.startPage | 239 | - |
dc.citation.title | 한국환경보건학회지 | - |
dc.citation.volume | 39 | - |
dc.citation.number | 3 | - |
dc.contributor.affiliatedAuthor | 장재선 | - |
dc.subject.keywordAuthor | Salmonella Enteritidis | - |
dc.subject.keywordAuthor | Salmonella Typhimurium | - |
dc.subject.keywordAuthor | diarrhea patient | - |
dc.subject.keywordAuthor | antimicrobial resistance | - |
dc.subject.keywordAuthor | multidrug resistance | - |
dc.description.journalRegisteredClass | kci | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114
COPYRIGHT 2020 Gachon University All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.